Chili's cancels fundraiser for anti-vax org; EU approves Joint Procurement; Cash incentives up hep B vax rates for drug users;

> Restaurant chain Chili's canceled a fundraiser benefiting an organization that claims a link between vaccines and autism after a vaccine-awareness Facebook group urged followers to boycott. More

> The EU has approved a Joint Procurement Agreement, enabling all EU countries to procure pandemic vaccines and other medical countermeasures as a group, rather than individually. Release

> Novavax ($NVAX) has appointed Cindy Oliver as its SVP of process development operations. Release

> Small cash incentives can dramatically improve hepatitis B vaccination rates among injecting drug users, a study has found. More

> Vaccinemakers in India, fed up with permissions delays, are moving their clinical trials elsewhere. More

> The FDA has accepted Stemline Therapeutics' ($STML) IND for a vaccine that targets glioma brain tumors. Release

> Immunovaccine presented positive clinical study data for its leading cancer vaccine, DPX-Survivac, at the American Association for Cancer Research's annual meeting. Release

> HPV vaccines may be less effective for black women, a new study suggests. More

> A Saudi corporation expects its three pork-free halal vaccines to be ready in three years. Report

And Finally... Two former directors of the WHO's smallpox eradication program suggest stockpiling the smallpox vaccine sufficient to cover 10% of the world's population, with 300 million additional doses in a WHO stockpile, in case of a terror-related outbreak. More

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.